Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Photocure ASA

Market Cap 1.57B 165M 142M 131M 123M 230M 15.57B 233M 1.55B 604M 7.63B 618M 605M 26.39B P/E Ratio 2026 *
19.3x
P/E Ratio 2027 * 30.8x
Enterprise Value 1.25B 131M 113M 104M 97.39M 183M 12.37B 185M 1.23B 479M 6.06B 491M 481M 20.96B EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.78x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-1.17%
1 week+1.37%
Current month-4.84%
1 month-5.90%
3 months-12.59%
6 months-8.81%
Current year-17.37%
1 week 56.2
Extreme 56.2
60.9
1 month 56.2
Extreme 56.2
67.8
Current year 55.2
Extreme 55.2
79.8
1 year 49.5
Extreme 49.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
145
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Executive Officer - 01/07/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/04/25BuyCompany 8,997 0.0332%
02/04/25BuyCompany 11,355 0.0419%
31/03/25BuyCompany 26,492 0.0977%
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%+1.37%+15.46%+18.00% 167M
-0.32%-1.72%+37.83%+148.79% 1,010B
-2.16%+1.51%+50.01%+43.93% 580B
-2.70%-0.66%+15.97%+63.07% 402B
-1.18%+1.05%+20.91%+18.37% 330B
-1.52%+2.45%+23.73%+33.03% 281B
-1.95%-4.32%+20.15%+12.96% 280B
-0.57%+5.00%-44.67%-48.28% 197B
-1.31%+1.39%+18.74%+53.45% 192B
-0.38%-2.97%+13.02%+57.34% 156B
Average -1.24%+0.16%+17.11%+40.07% 342.89B
Weighted average by Cap. -1.03%-0.16%+26.15%+67.03%

Financials

2026 *2027 *
Net sales 634M 66.6M 57.4M 52.83M 49.56M 93.1M 6.29B 94.03M 625M 244M 3.08B 250M 245M 10.67B 676M 70.91M 61.11M 56.25M 52.76M 99.12M 6.7B 100M 665M 260M 3.28B 266M 260M 11.36B
Net income 81.5M 8.55M 7.37M 6.79M 6.37M 11.96M 809M 12.08M 80.23M 31.34M 396M 32.1M 31.42M 1.37B 51M 5.35M 4.61M 4.25M 3.98M 7.48M 506M 7.56M 50.2M 19.61M 248M 20.09M 19.66M 857M
Net Debt -323M -33.9M -29.22M -26.89M -25.23M -47.39M -3.2B -47.87M -318M -124M -1.57B -127M -125M -5.43B -365M -38.31M -33.02M -30.39M -28.51M -53.56M -3.62B -54.09M -359M -140M -1.77B -144M -141M -6.14B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
15/06/26 59.00 kr -1.17% 33,481
12/06/26 59.70 kr +3.11% 50,507
11/06/26 57.90 kr +0.87% 31,364
10/06/26 57.40 kr 0.00% 102,319
09/06/26 57.40 kr -1.37% 60,795
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
59.00NOK
Average target price
85.00NOK
Spread / Average Target
+44.07%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!